Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background Debate exists as to whether the higher hemoglobin A1c (HbA1c) levels observed in black persons than in white persons are due to worse glycemic control or racial differences in the glycation of hemoglobin. Objective To determine whether a racial difference exists in the relationship of mean glucose and HbA1c. Design Prospective, 12-week observational study. Setting 10 diabetes centers in the United States. Participants 104 black persons and 104 white persons aged 8 years or older who had had type 1 diabetes for at least 2 years and had an HbA1c level of 6.0% to 12.0%. Measurements Mean glucose concentration, measured by using continuous glucose monitoring and compared by race with HbA1c, glycated albumin, and fructosamine values. Results The mean HbA1c level was 9.1% in black persons and 8.3% in white persons. For a given HbA1c level, the mean glucose concentration was significantly lower in black persons than in white persons (P = 0.013), which was reflected in mean HbA1c values in black persons being 0.4 percentage points (95% CI, 0.2 to 0.6 percentage points) higher than those in white persons for a given mean glucose concentration. In contrast, no significant racial differences were found in the relationship of glycated albumin and fructosamine levels with the mean glucose concentration (P > 0.20 for both comparisons). Limitation There were too few participants with HbA1c levels less than 6.5% to generalize the results to such individuals. Conclusion On average,…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A1C levels may be 0.4% to 0.6% higher in Blacks and Hispanics compared with Whites, despite equivalent levels of hyperglycemia in those with T2D.11-17”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [17]
In the citing paper
“At the same average glucose values, HbA 1c was approximately 0.4% higher in the former compared with the latter.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [342]
In the citing paper
“A study in type 1 diabetes demonstrated a difference in the relationship between mean average glucose measured with CGM and HbA 1c in Black compared with White participants (342).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [342]
In the citing paper
“As discussed in section 2, “Diagnosis and Classification of Diabetes,” there is controversy regarding the clinical significance of differences in A1C by self-reported race and ethnicity (9)(10)(11)(12).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [9]
In the citing paper
“Studies have found that African American individuals have slightly higher A1C levels than non-Hispanic White or Hispanic people (22 -25).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [22]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Self-citationContinuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 737 · cited 1×
“Food and Drug Administration approval after the study (25, 26).”
BackgroundThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 2×
“Food and Drug Administration approval after the study (25, 26).”
BackgroundMethodHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c
Cohen, R. M., Franco, R. S., Khera, P. K., Smith, E. P., Lindsell, C. J., Ciraolo, P. J., Palascak, M. B., & Joiner, C. H. (2008) · Blood · doi:10.1182/blood-2008-04-154112 · Cited by 478 · cited 2×
“8) Age, n (%) 8 to <13 y 17 (14) 21 (20) 13 to <18 y 24 (19) 31 (29) 18 to <30 y 20 (16) 12 (11) 30 to <50 y 39 (31) 22 (21) ≥50 y 25 (20) 21 (20) Female, n (%) 62 (60) 55 (53) Annual household income, n (%) <$50 000 44 (59) 18 (23) $50 000 to <$100 000 24 (32) 23 (30) ≥$100 000 7 (9) 36 (47) Mean duration of diabetes…”
BackgroundThe fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
Self-citationA1c versus glucose testing: a comparison
Sacks, D. B. (2011) · Diabetes Care · doi:10.2337/dc10-1546 · Cited by 461 · cited 2×
“8) Age, n (%) 8 to <13 y 17 (14) 21 (20) 13 to <18 y 24 (19) 31 (29) 18 to <30 y 20 (16) 12 (11) 30 to <50 y 39 (31) 22 (21) ≥50 y 25 (20) 21 (20) Female, n (%) 62 (60) 55 (53) Annual household income, n (%) <$50 000 44 (59) 18 (23) $50 000 to <$100 000 24 (32) 23 (30) ≥$100 000 7 (9) 36 (47) Mean duration of diabetes…”
BackgroundGlycemic control in youth with diabetes: the SEARCH for Diabetes in Youth Study
Petitti, D. B., Klingensmith, G. J., Bell, R. A., Andrews, J. S., Dabelea, D., Imperatore, G., Marcovina, S., Pihoker, C., Standiford, D., Waitzfelder, B., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.05.025 · Cited by 397
Self-citationTahara, Y., & Shima, K. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.440 · Cited by 380 · cited 3×
“Similar analyses to those described above were conducted for fructosamine and glycated albumin, using a maximum of 42 and 53 days of prior CGM data, respectively (28).”
MethodInfluentialRacial-ethnic disparities in management and outcomes among children with type 1 diabetes
Willi, S. M., Miller, K. M., DiMeglio, L. A., Klingensmith, G. J., Simmons, J. H., Tamborlane, W. V., Nadeau, K. J., Kittelsrud, J. M., Huckfeldt, P., Beck, R. W., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-1774 · Cited by 367
Self-citation
Research works printed but not linked: 1
- Boltri JM, 2005, Ethn Dis, 15, 562
Cited by
Items 201–300 of 318
Mean blood glucose‐independent HbA1c racial disparity and iron status in youth with Type 1 DM
Hamdan, M. A. A., Gómez, R., & Chalew, S. A. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13002 · Cited by 7
“Multiple studies have reported that Blacks have higher HbA1c levels than Whites after adjustment for concurrent levels of blood glucose.(6-9) The mechanism/s for this glucose-independent racial disparity in HbA1c are unclear.”
BackgroundStaimez, L. R., Rhee, M. K., Deng, Y., Safo, S. E., Butler, S. M., Legvold, B. T., Jackson, S. L., Ford, C. N., Wilson, P. W. F., Long, Q., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14289 · Cited by 7
Optimizing Diabetes Care With the Standardized Continuous Glucose Monitoring Report
Chun, J. H., & O’Neill, M. S. (2020) · Clinical Diabetes · doi:10.2337/cd19-0066 · Cited by 7
The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring
Kushner, P. R., & Kruger, D. F. (2020) · Clinical Diabetes · doi:10.2337/cd19-0093 · Cited by 7
Self-citationGlucose-independent racial disparity in HbA1c is evident at onset of type 1 diabetes
Alaqeel, A. A., Gómez, R., & Chalew, S. A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108229 · Cited by 7
Simulating Realistic Continuous Glucose Monitor Time Series By Data Augmentation
Gomez, L., Toye, A. A., Hum, R. S., & Kleinberg, S. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231181138 · Cited by 7
Imuro, S. E. S., Sabharwal, A., Bevier, W. C., & Kerr, D. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-72837-7 · Cited by 7
“The study should also include participants with both T1D and T2D and confirm the validity of the suggested reference values.”
BackgroundInfluentialXu, Y., Oriot, P., Dunn, T. C., Hermans, M. P., Ram, Y., Cheng, A., & Ajjan, R. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14824 · Cited by 6
Ha, M.-T., Dao, T.-T., & Nguyen, T.-A. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100175 · Cited by 8
Racial and Ethnic Disparities in Diabetes Clinical Care and Management: A Narrative Review
Young, C., & Myers, A. K. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.11.013 · Cited by 7
Niwaha, A. J., Balungi, P., McDonald, T. J., Hattersley, A. T., Shields, B. M., Nyirenda, M., & Jones, A. G. (2025) · Diabetic Medicine · doi:10.1111/dme.70011 · Cited by 7
“9,10 Alternative markers of chronic glycaemia, including fructosamine and glycated albumin (GA) have been proposed, in patients for whom HbA 1c may be unreliable.”
Adeleye, K. K., Tomiwa, O., Kwapong, Y. A., Boakye, E., Adebowale, O. N., Owusu, B., Turkson‐Ocran, R., Commodore-Mensah, Y. Y., & Ogungbe, O. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038518 · Cited by 5
“29,30 The persistent nature of this disparity suggests ongoing systemic issues in health care delivery and access for NH Black and Hispanic individuals, including discriminatory delivery of high-quality care.”
Samajdar, S. S., Joshi, S., Misra, A., & Vikram, N. K. (2026) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2026.100724 · Cited by 7
Ajjan, R., Choudhary, P., Xu, Y., & Dunn, T. C. (2026) · Diabetes Care · doi:10.2337/dc26-0398 · Cited by 5
Gurnurkar, S., Owens, L. L., Chalise, S., & VYAS, N. V. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0587 · Cited by 6
McKee, A. M., Al-Hammadi, N. J., & Hinyard, L. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.05.001 · Cited by 5
Abdoli, S., Odoi, E. W., Irani, M. D., Fanti, P., & Beebe, L. H. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221102863 · Cited by 6
Filteau, S., Kasonka, L., Wells, J. C. K., Munthali, G., Chisenga, M., & Rehman, A. M. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522001775 · Cited by 5
“%) of the cohort with high HbA1c, possibly due to differences in genetic ancestry (25) .”
Nwosu, B. U. (2018) · Diabetes Care · doi:10.2337/dc18-0483 · Cited by 5
Glucose management indicator: Do we need device-specific equations?
Jávorfi, T., Kocsis, G., Svébis, M. M., Ferencz, V., Domján, B. A., Kézdi, Á., Hankó, H., Putz, Z., & Tabák, Á. G. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101661 · Cited by 4
Tallon, E. M., Williams, D. D., Schweisberger, C., Mullaney, C., Lockee, B., Ferro, D., Vandervelden, C. A., Barnes, M. S., Sarteau, A. C., Kahkoska, A. R., et al. (2025) · JMIR Diabetes · doi:10.2196/69142 · Cited by 4
“Generalizability of these HbA 1c prediction efforts is limited, however, by these methods’ dependence on CGM data and by racial disparities in the relationship between CGM metrics and HbA 1c [56].”
Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV
Hahn, A. W., Ruderman, S. A., Nance, R. M., Whitney, B. M., Eltonsy, S., Haidar, L., Drumright, L. N., Ma, J., Mayer, K. H., Napravnik, S., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0236 · Cited by 4
Disparities in Glycemic Outcomes Persist in Youth with Type 1 Diabetes and High-Technology Use
Nath, M. C., Frey, B. F., Atchison, J. A., & Schmitt, J. A. (2023) · Pediatric Diabetes · doi:10.1155/2023/6646582 · Cited by 4
“This prior work is limited however in including only mean of FSBG [4] or 14-day CGM data [5].”
Verbeeten, K. C., Tang, K., Courtney, J. M., Bradley, B. J., McAssey, K., Clarson, C. L., Kirsch, S. E., Curtis, J. R., Mahmud, F. H., Richardson, C., et al. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.04.007 · Cited by 4
Paprocki, J. D., Macdonald, P. J., Xu, Y., Cheng, A., Dunn, T. C., & Tetin, S. Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-74574-3 · Cited by 4
Kinney, G. L., Young, K. A., Lamb, M. M., Orchard, T. J., Cai, J., Hosgood, D., Klein, O. L., Talavera, G. A., Young, L. D., & Daviglus, M. L. (2019) · Epidemiology · doi:10.1097/ede.0000000000001125 · Cited by 4
Chaychenko, T., Argente, J., Spiliotis, B. E., Wabitsch, M., & Marcus, C. (2020) · Hormone Research in Paediatrics · doi:10.1159/000515730 · Cited by 4
Time in range measurements for hyperglycemia management during pregnancy
Wang, S., Xin, H., Li, L., & Li, P. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.03.017 · Cited by 5
Hoffmann, A. P., & Honigberg, M. C. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01024-8 · Cited by 6
Virtual insulin pump initiation is safe effective in children adolescents with type 1 diabetes
Nwosu, B. U., Pellizzari, M., Pavlovic, M. N., Ciron, J., Talib, R., & Sohail, R. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1362627 · Cited by 4
Therapie des Typ-1-Diabetes: Kurzfassung der S3-Leitlinie. Version 5.0, AWMF-Registernummer: 057-013
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-0276 · Cited by 6
Thomsen, H. B., Li, L. Y., Isaksen, A. A., Lebiecka-Johansen, B., Bour, C., Fagherazzi, G., van Doorn, W. P. T. M., Varga, T. V., & Hulmán, Á. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0000918 · Cited by 4
Bloomgarden, Z. T. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12910 · Cited by 4
“4% higher than nonHispanic Whites,(14) although such differences are not observed in glycated albumin or fructosamine.(15) Because of these concerns, other approaches to measurement of glycemia have been sought in endeavoring to understand glycemic exposure.”
BackgroundBeyond A1C: A Practical Approach to Interpreting and Optimizing Continuous Glucose Data in Youth
Al-Gadi, I., Menon, S., Lyons, S. K., & DeSalvo, D. J. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0095 · Cited by 4
Ram, N., Ahmed, S., Sattar, S., Furqan, S., & Islam, N. (2021) · Cureus · doi:10.7759/cureus.18435 · Cited by 4
“has revealed population differences in A1c levels, where it was significantly higher in blacks compared to white subjects, in relation to plasma glucose lower than white population [13].”
BackgroundMonitoring of paediatric type 1 diabetes
Marks, B. E., & Wolfsdorf, J. I. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001136 · Cited by 6
“4% higher than that of non-Hispanic white persons for a given mean glucose concentrationmeasured using CGM [6].”
Daultrey, H. E., Oliver, N. S., Wright, J. E., Levett, T. J., & Chakera, A. J. (2024) · Diabetes Care · doi:10.2337/dc24-0225 · Cited by 4
Dirks, R. C., Burney, H. N., Anjanappa, M., Sandusky, G. E., Hao, Y., Liu, Y., Schmidt, C. M., & Nakshatri, H. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2020.03.035 · Cited by 4
“Even hemoglobin A1c, a common clinical biomarker, shows racial differences in its relationship to circulating glucose concentrations.(36) This study did have additional limitations worth noting.”
BackgroundDadwani, R. S., Skandari, M. R., GoodSmith, M. S., Phillips, L. S., Rhee, M. K., & Laiteerapong, N. (2020) · Diabetic Medicine · doi:10.1111/dme.14330 · Cited by 6
Usefulness of estimated average glucose (eAG) in glycemic control and cardiovascular risk reduction
Wang, D., & Chen, Y. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.06.009 · Cited by 5
Use of Retrospective Continuous Glucose Monitoring Data Is Underrated and Underused
Nguyen, Q., Iyyavoo, A. A., & Parkin, C. G. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211070837 · Cited by 4
Stimson, R. H., Crane, M. S., Dover, A. R., Forbes, S., Wright, R. J., Lyall, M. J., Strachan, M. W. J., & Gibb, F. W. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70365 · Cited by 3
Osei, E. P., Campos, S., & Martyn-Nemeth, P. A. (2025) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106251397917 · Cited by 4
Huang, L., He, L., Zeng, Q., Huang, J., Luo, X., & Zhong, Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1416506 · Cited by 3
Flash Glucose Monitoring: A Patient's and Clinician's Caveats and Concerns
Argento, N. B. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0216 · Cited by 3
Tseng, C., Aron, D. C., Soroka, O., Lu, S., Myers, C. E., & POGACH, L. M. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107475 · Cited by 3
Wang, J., Lee, I., Lee, W., Lin, S., Lee, W.-L., Liang, K., & Sheu, W. H. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001646 · Cited by 3
van Olden, C. C., Muilwijk, M., Stronks, K., van den Born, B. H., van Charante, E. P. M., Nicolau, M. J., Zwinderma, A. H., Nieuwdorp, M., Groen, A. K., & van Valkengoed, I. G. M. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109859 · Cited by 4
Can HbA1c Alone Be Safely Used to Guide Insulin Therapy in African Youth with Type 1 Diabetes?
Piloya, T., Mungai, L., Moran, A., Yauch, L. M., Christakis, N. J., Zhang, L., McCarter, R., & Chalew, S. A. (2023) · Pediatric Diabetes · doi:10.1155/2023/1179830 · Cited by 3
Parimi, V., Elsner, A. E., Gast, T. J., Chen, Z., Baskaran, K., Alhamami, M. A., Litvin, T. V., Ozawa, G. Y., & Cuadros, J. A. (2024) · Optometry and Vision Science · doi:10.1097/opx.0000000000002096 · Cited by 3
IGUDESMAN, D. A., Reboussin, B. A., Souris, K. J., Pihoker, C., Dolan, L. M., Lawrence, J. M., Saydah, S., Dabelea, D., Marcovina, S. M., Clouet-Foraison, N., et al. (2022) · Journal of Diabetes Research · doi:10.1155/2022/8554991 · Cited by 3
“Likewise, disparities in glycemic outcomes among minority youth with T1D are not fully explained by biological [16], clinical, or demographic factors [17].”
BackgroundSelf-citationGlycated Albumin: Added Value or Redundancy in Diabetes Care?
Kirkman, M. S., & Sacks, D. B. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab261 · Cited by 3
Misuse of Race in the Interpretation of HbA1c
Selvin, E. (2024) · Annals of Internal Medicine · doi:10.7326/annals-24-01661 · Cited by 3
“These racial differences are small, typically about 0.3%- points HbA 1c (3), similar in magnitude to the methodological error of many HbA 1c assays.”
InfluentialPiloya, T., Nyangabayaki, C., Dunn, T. C., MALINGA, D., JEMIMA, N., Pappenfus, E., Zhang, L., Bindal, A., Beasley, S., Sunni, M., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0537 · Cited by 2
“In addition, the Ugandans exhibited a much wider range of A1c levels for any given MG compared with those in the other two data sets.”
Fernandez, E. C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1856036 · Cited by 2
“Its limitations — including insensitivity to glycemic variability, dependence on erythrocyte lifespan, and racial/ethnic variation in HbA1c-glucose relationships — are well documented (39, 40).”
Neural Architecture Search for Blood Glucose Prediction in Type-1 Diabetics
Liardo, A., Ray, A., Firouzi, F., Lafata, K. J., & Chakrabarty, K. (2024) · Wearable and Implantable Body Sensor Networks · doi:10.1109/bsn63547.2024.10780668 · Cited by 2
Vijayakumar, V., Mavathur, R. N., Mooventhan, A., & Krishnamurthy, M. N. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12649 · Cited by 2
“Variations in HbA1c among different ethnic groups have also been reported.(4) These reports suggest that measurement of baseline HbA1c levels”
BackgroundChalew, S. A., & Gómez, R. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12863 · Cited by 4
LeBlanc, E. S., Pittas, A. G., Nelson, J., Chatterjee, R., Rasouli, N., Rhee, M. K., Pratley, R. E., Desouza, C. V., Neff, L. M., Peters, A. M., et al. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003613 · Cited by 2
The Role of Hemoglobin A1C in Diabetes Screening and Diabetic Retinopathy
Villacreses, M. M. C., Karnchanasorn, R., Ou, H., Samoa, R. A., Chuang, L., & Chiu, K. C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214947 · Cited by 1
Bruhn, L., Vistisen, D., Amadid, H., Clemmensen, K. K. B., Karstoft, K., Ried‐Larsen, M., Persson, F., Jørgensen, M. E., Møller, C. L., Stallknecht, B. M., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03384-w · Cited by 1
“Previous studies have found discrepancies between HbA1c and other measures of glycemia [11, 27, 28] and this seems to be particularly true”
ResultPrimary care diabetes assessment when HbA1c and other measures of glycemia disagree
Friedman, J. G., Smith, E. P., Awasty, S. S., Behan, M., Genco, M. T., Hempel, H. C., Jafri, S., Jandarov, R., Nagaraj, T., Franco, R. S., et al. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2023.12.005 · Cited by 1
Manov, A. E., Holt, N., Dini, E., Rivera, R., Donepudi, A., Haddadin, R. W., Mefferd, K., & Qadir, I. (2024) · Cureus · doi:10.7759/cureus.56768 · Cited by 1
“The study population was mostly Caucasians, excluding African Americans, who, on average, have higher HbA1c [13].”
BackgroundRecent advances and perspectives in novel insulin release systems
Barkhordari, S., Samandari, S. S., Abdouss, M., & Pourmadadi, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106500 · Cited by 2
Rodríguez, Á., Rodríguez, J., Camiña, F., Devesa, J. B. O., & Rodríguez‐Segade, S. (2025) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2024-0125 · Cited by 2
“Además, los resultados de las pruebas pueden verse afectados por diferencias étnicas/raciales en las tasas de glicosilación y en situaciones como el embarazo [17 – 20].”
Alnissayan, A. I. A., Almasaari, F. H., Alothman, N. H., Almalki, B. A., Alhajri, S. M. S., Alamri, O., Alshehri, K., Bukhari, K. O., Alshamrani, A. A., Alhabib, A. T., et al. (2024) · Journal of Posthumanism · doi:10.63332/joph.v4i3.3413 · Cited by 1
Huang, B., Zheng, M., Li, J., Fang, C., Wu, Y., Xiao, Y., Yu, P., Gu, W., Zhou, S., Zhang, Y., et al. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02067-y · Cited by 1
“Second, previous studies have demonstrated racial differences in HbA1c levels at a given mean glucose concentration [51, 52].”
Homer, V., Brophy, C., French, R., Krayem, A., Pérez, S. P., Warner, J., & Dias, R. P. (2026) · Diabetic Medicine · doi:10.1111/dme.70283 · Cited by 1
“29 We did not have real-time (rt)CGM data to correlate HbA1c in this national cohort but a recent study from the United States showed differences in HbA1c in Black children compared to White children despite adjusting for mean glucose.”
Labile Hemoglobin A1c (LHbA1c): From analytical interference to clinically valuable biomarker
Wang, K., & Han, W. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121018 · Cited by 1
Pendley, B. D., & Lindner, E. (2017) · Electroanalysis · doi:10.1002/elan.201700694 · Cited by 1
Racial Differences in Trajectories of Hemoglobin A1c: Further Evidence of Gaps in Care
Miller, K. M. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1882 · Cited by 1
Kong, L.-R., Zhang, Y., Wu, F., Wen, X.-Q., He, D.-H., Zhou, C., & Wang, L. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107796 · Cited by 1
Archie, C. N., Das, D., Meskaran, F., & David, L. G. (2022) · International Conference on Distributed Computing and Electrical Circuits and Electronics (ICDCECE) · doi:10.1109/icdcece53908.2022.9792995 · Cited by 1
Lu, Y., Wang, X., Zhang, Q., & Xue, Y. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01305-1 · Cited by 1
Salasa, W., Seredyński, T., Mądry, W., Mazurkiewicz, A., Kołodziej, M., Męczyńska, J., Saiuk, N., Kozicz, M. A., Wojciechowska, A., & Marcicka, J. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.67.50885 · Cited by 1
Block, C. E. M. D., CHENG, A. Y. Y., Anil, G., D’Cruz, J. M., & Ginovker, A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01603-9 · Cited by 1
“Racial differences in HbA1c have also been observed, with HbA1c reported to be 0.4% higher in Black than in White persons for the same mean glucose concentration [21], further demonstrating the potential importance of using alternative measures for glycemic control.”
InfluentialSchmitt, J. A., Nath, M. C., Richman, J., & Atchison, J. A. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13602 · Cited by 1
Analysis of Clinical Data on the Treatment of Type 2 Diabetes with BMPRP
Liu, B., Gao, X., Chen, Y., Zheng, R., Dong, Q., & Wang, J. (2024) · American Journal of Bioscience and Bioengineering · doi:10.11648/j.bio.20241206.14 · Cited by 1
“Traditional medical treatment cannot solve the source of insulin resistance and islet beta cell dysfunction [11-15], in order to overcome this situation, the focus of research has shifted to the field of stem cell therapy for diabetes [16-20].”
Obesity and Cardiovascular-Kidney-Metabolic Health
Ghanta, S. N., Lessey, C., Makwana, B., Ganatra, S., & Dani, S. S. (2025) · Cardiology Clinics · doi:10.1016/j.ccl.2024.12.009 · Cited by 1
Kyriacou, A., Evans, J. M. M., & Kyriacou, A. (2017) · Endocrine Abstracts · doi:10.1530/endoabs.49.ep481 · Cited by 1
RELATIONSHIP BETWEEN ESTIMATED AVERAGE GLUCOSE AND GLYCATED HEMOGLOBIN
Khan, S. H., Fazal, N., Gilani, A. A. S., Asif, N., Ijaz, A., Manzoor, S. M., Yasir, M., & Niazi, N. S. K. (2018) · Journal of Postgraduate Medical Institute
Screening and Diagnosis of Type II Diabetes
Michaud, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55138-0.00004-8
Point-of-care testing in diabetes management
Cozma, A., Vonica, C. L., Sitar-Tăut, A., & Fodor, A. (2019) · Revista română de medicină de laborator · doi:10.2478/rrlm-2019-0014
“African Americans have higher HbA1c values compared to non-Hispanic whites for a given mean BG concentration (54).”
BackgroundBergenstal, R. M., & Beck, R. W. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.3233
Self-citationNew Trends: Time in Range and the Use of Continuous Glucose Monitoring Devices on Glycemic Control
Souza, K. L. V. D., Rassi, M. M. B., de Sá, D. A. R., Bussuan, R. M., Rodrigues, L. C. D. S., & Arbex, A. K. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.1.491 · Cited by 1
“One study demonstrated a range of ∼80 mg/dL in average glucose for the same A1C level [89].”
BackgroundA More Intentional Analysis of Race and Racism in Research
Kaiksow, F. A., Unaka, N. I., & Jones, C. D. (2021) · Journal of Hospital Medicine · doi:10.12788/jhm.3674
„Time in range“ (TIR) vs. Glykohämoglobin Typ A1c (HbA1c): was zählt für unsere Patienten?
Harer, C., & Mader, J. K. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00963-9
Fasting plasma glucose and hemoglobin a1c differ by gender and race among emerging adults
Healy, M. E., Wilson, O. W. A., & Bopp, C. M. (2021) · Journal of Kinesiology & Wellness · doi:10.56980/jkw.v10i.88
Do not report estimated average glucose (eAG) from HbA1c: Evidence is emerging
Chen, Y. (2023) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2023.110677
Positioning “Time-in-Range” in the Treatment of Diabetes in India
Mohan, V., Unnikrishnan, A. G., Kesavadev, J., & Saboo, B. (2022) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_2_22
Étude de l’hémoglobine glyquée chez des patients diabétiques de type 1
Gloaguen, E. (2020) · theses.fr (ABES) · doi:10.70675/3b72a235z559dz4bf3z8ee7zdc9cd3693991
Mesure continue du glucose : quels sont les nouveaux indicateurs de suivi ?
Joubert, M. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.05.001 · Cited by 1
Barnabas, R., Shivane, V. K., Tamoli, S., Mahadik, S., Memon, S. S., Bandgar, T., & Mehta, B. (2024) · Medical Research Archives · doi:10.18103/mra.v12i12.6048
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2025) · Die Diabetologie · doi:10.1007/s11428-024-01280-z
Glycemic Goals and Assessment of Glycemia
(2022) · American Diabetes Association eBooks · doi:10.2337/9781580407700.ch02
The impact of the COVID-19 pandemic on DKA severity in Black and White pediatric patients
Patel, S., Amador, E., Fischell, J. M., Bewley, E., Jeffries, K., Newton, P. G., & Fischell, S. Z. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0526
Sobczak, M., Pyle, L. L., Sawyer, A., Forlenza, G. P., & Alonso, G. T. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0500 · Cited by 1
Alnissayan, A. I. A., Almasaari, F. H., Alothman, N. H., Almalki, B. A., Alhajri, S. M. S., Alamri, O., Alshehri, K., Bukhari, K. O., Alshamrani, A. A., Alhabib, A. T., et al. (2025) · Journal of Posthumanism · doi:10.63332/joph.v5i9.3413
“However, the interpretation of HbA1c is compromised by the variability related to ethnicity, hemoglobinopathies, and certain comorbidities (Bergenstal et al., 2018).”
Homer, V., Brophy, C., French, R., Krayem, A., Pon-Perez, S., Warner, J., & Dias, R. P. (2025) · Endocrine Abstracts · doi:10.1530/endoabs.111.oc9.5
Metadata
- Authors
- Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., Rickels, M., DiMeglio, L. A., Bethin, K. E., Marcovina, S., Tassopoulos, A., Lee, S., Massaro, E., Bzdick, S., Ichihara, B., Markmann, E., McGuigan, P., Woerner, S., Ecker, M., Beck, R. W., & for the T1D Exchange Racial Differences Study Group*
- Affiliations
- Children's Hospital of Philadelphia (US)
- From International Diabetes Center Park Nicollet, Minneapolis, Minnesota; Jaeb Center for Health Research, Tampa, Florida; University Hospitals of Cleveland, Cleveland, Ohio; Henry Ford Health System, Detroit, Michigan; Children's Hospital of Philadelphia and Perelman School of Medicine and Rodebaugh Diabetes Center, University of Pennsylvania, Philadelphia, Pennsylvania; Northwestern University, Chicago, Illinois; SUNY Upstate Medical University, Syracuse, New York;
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-07-18
- Volume
- 167
- Issue
- 2
- Pages
- 95-102
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2625092562
- Semantic Scholar
- f0f7e81895f364d37c2c4682799f26717d554b9e
- Cited by
- 306
- References
- 40
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 32 · 2023: 29 · 2022: 39 · 2021: 40 · 2020: 41 · 2019: 31 · 2018: 37 · 2017: 11
- FWCI
- 25.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- Abbott Diabetes Care
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- HbA1c, racial differences, type 1 diabetes, glycemic control, hemoglobin glycation, glycated albumin, fructosamine, Black patients, continuous glucose monitoring
- MeSH terms
- Glycated Serum Albumin, Adolescent, Adult, Black or African American, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Prospective Studies, Serum Albumin, United States, Blood Glucose Self-Monitoring, Glycation End Products, Advanced, Fructosamine, Black People, White People, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.